Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_assertion type Assertion NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_head.
- NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_assertion description "[Interestingly, drugs used for other diseases, such as statins, Rho-kinase inhibitors, imatinib mesylate, may control the pathological vascular remodeling of PAH.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_provenance.
- NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_assertion evidence source_evidence_literature NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_provenance.
- NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_assertion SIO_000772 17346158 NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_provenance.
- NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_assertion wasDerivedFrom befree-20140225 NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_provenance.
- NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_assertion wasGeneratedBy ECO_0000203 NP675816.RA0_XtpcuduZ05RPqWL6bgl33frqS08x1Q7tPNlOlOgTE130_provenance.